General MedicationsTOPICALStandard
KLARON
SULFACETAMIDE SODIUM
Standard Dose
10%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview KLARON is listed in Drugs@FDA under application 019931 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SULFACETAMIDE SODIUM Form and strength LOTION;TOPICAL - 10% Sponsor BAUSCH Submission history Latest submission status date: 2016-02-16 00:00:00.
Structured Monograph
Clinical summary
Approval overview KLARON is listed in Drugs@FDA under application 019931 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SULFACETAMIDE SODIUM Form and strength LOTION;TOPICAL - 10% Sponsor BAUSCH Submission history Latest submission status date: 2016-02-16 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.